Literature DB >> 29307198

Inherited pancreatic cancer.

Fei Chen1, Nicholas J Roberts2, Alison P Klein3.   

Abstract

Pancreatic cancers arise through a series of genetic events both inherited and acquired. Inherited genetic changes, both high penetrance and low penetrance, are an important component of pancreatic cancer risk, and may be used to characterize populations who will benefit from early detection. Furthermore, pancreatic cancer patients with inherited mutations may be particularly sensitive to certain targeted agents, providing an opportunity to personalized treatment. Family history of pancreatic cancer is one of the strongest risk factors for the disease, and is associated with an increased risk of caners at other sites, including but not limited to breast, ovarian and colorectal cancer. The goal of this chapter is to discuss the importance of family history of pancreatic cancer, and the known genes that account for a portion of the familial clustering of pancreatic cancer.

Entities:  

Keywords:  Familial pancreatic cancer (FPC); genetic syndromes; genome-wide association

Mesh:

Year:  2017        PMID: 29307198      PMCID: PMC5873957          DOI: 10.21037/cco.2017.12.04

Source DB:  PubMed          Journal:  Chin Clin Oncol        ISSN: 2304-3865


  193 in total

1.  Adenocarcinoma of the pancreas in four siblings.

Authors:  R P MacDermott; P Kramer
Journal:  Gastroenterology       Date:  1973-07       Impact factor: 22.682

2.  Expression of master regulatory genes of embryonic development in pancreatic tumors.

Authors:  L G Kondratyeva; I P Chernov; M V Zinovyeva; E P Kopantzev; E D Sverdlov
Journal:  Dokl Biochem Biophys       Date:  2017-09-02       Impact factor: 0.788

3.  Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas.

Authors:  Benoit Terris; Ekaterina Blaveri; Tatjana Crnogorac-Jurcevic; Melanie Jones; Edoardo Missiaglia; Philippe Ruszniewski; Alain Sauvanet; Nicholas R Lemoine
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

4.  PALB2 mutations in familial breast and pancreatic cancer.

Authors:  Erin W Hofstatter; Susan M Domchek; Alexander Miron; Judy Garber; Molin Wang; Kathryn Componeschi; Leigh Boghossian; Penelope L Miron; Katherine L Nathanson; Nadine Tung
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

5.  CHEK2 mutation and risk of prostate cancer: a systematic review and meta-analysis.

Authors:  Yue Wang; Bo Dai; Dingwei Ye
Journal:  Int J Clin Exp Med       Date:  2015-09-15

6.  ABO blood group and the risk of pancreatic cancer.

Authors:  Brian M Wolpin; Andrew T Chan; Patricia Hartge; Stephen J Chanock; Peter Kraft; David J Hunter; Edward L Giovannucci; Charles S Fuchs
Journal:  J Natl Cancer Inst       Date:  2009-03-10       Impact factor: 13.506

7.  Prospective risk of cancer and the influence of tobacco use in carriers of the p16-Leiden germline variant.

Authors:  Thomas P Potjer; Heidi E Kranenburg; Wilma Bergman; Wouter H de Vos tot Nederveen Cappel; Hester S van Monsjou; Daniela Q C M Barge-Schaapveld; Hans F A Vasen
Journal:  Eur J Hum Genet       Date:  2014-09-17       Impact factor: 4.246

Review 8.  p130Cas: a key signalling node in health and disease.

Authors:  Angela Barrett; Caroline Pellet-Many; Ian C Zachary; Ian M Evans; Paul Frankel
Journal:  Cell Signal       Date:  2012-12-29       Impact factor: 4.315

9.  BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study.

Authors:  David B Zhen; Kari G Rabe; Steven Gallinger; Sapna Syngal; Ann G Schwartz; Michael G Goggins; Ralph H Hruban; Michele L Cote; Robert R McWilliams; Nicholas J Roberts; Lisa A Cannon-Albright; Donghui Li; Kelsey Moyes; Richard J Wenstrup; Anne-Renee Hartman; Daniela Seminara; Alison P Klein; Gloria M Petersen
Journal:  Genet Med       Date:  2014-11-20       Impact factor: 8.822

10.  Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.

Authors:  Brian M Wolpin; Cosmeri Rizzato; Peter Kraft; Charles Kooperberg; Gloria M Petersen; Zhaoming Wang; Alan A Arslan; Laura Beane-Freeman; Paige M Bracci; Julie Buring; Federico Canzian; Eric J Duell; Steven Gallinger; Graham G Giles; Gary E Goodman; Phyllis J Goodman; Eric J Jacobs; Aruna Kamineni; Alison P Klein; Laurence N Kolonel; Matthew H Kulke; Donghui Li; Núria Malats; Sara H Olson; Harvey A Risch; Howard D Sesso; Kala Visvanathan; Emily White; Wei Zheng; Christian C Abnet; Demetrius Albanes; Gabriella Andreotti; Melissa A Austin; Richard Barfield; Daniela Basso; Sonja I Berndt; Marie-Christine Boutron-Ruault; Michelle Brotzman; Markus W Büchler; H Bas Bueno-de-Mesquita; Peter Bugert; Laurie Burdette; Daniele Campa; Neil E Caporaso; Gabriele Capurso; Charles Chung; Michelle Cotterchio; Eithne Costello; Joanne Elena; Niccola Funel; J Michael Gaziano; Nathalia A Giese; Edward L Giovannucci; Michael Goggins; Megan J Gorman; Myron Gross; Christopher A Haiman; Manal Hassan; Kathy J Helzlsouer; Brian E Henderson; Elizabeth A Holly; Nan Hu; David J Hunter; Federico Innocenti; Mazda Jenab; Rudolf Kaaks; Timothy J Key; Kay-Tee Khaw; Eric A Klein; Manolis Kogevinas; Vittorio Krogh; Juozas Kupcinskas; Robert C Kurtz; Andrea LaCroix; Maria T Landi; Stefano Landi; Loic Le Marchand; Andrea Mambrini; Satu Mannisto; Roger L Milne; Yusuke Nakamura; Ann L Oberg; Kouros Owzar; Alpa V Patel; Petra H M Peeters; Ulrike Peters; Raffaele Pezzilli; Ada Piepoli; Miquel Porta; Francisco X Real; Elio Riboli; Nathaniel Rothman; Aldo Scarpa; Xiao-Ou Shu; Debra T Silverman; Pavel Soucek; Malin Sund; Renata Talar-Wojnarowska; Philip R Taylor; George E Theodoropoulos; Mark Thornquist; Anne Tjønneland; Geoffrey S Tobias; Dimitrios Trichopoulos; Pavel Vodicka; Jean Wactawski-Wende; Nicolas Wentzensen; Chen Wu; Herbert Yu; Kai Yu; Anne Zeleniuch-Jacquotte; Robert Hoover; Patricia Hartge; Charles Fuchs; Stephen J Chanock; Rachael S Stolzenberg-Solomon; Laufey T Amundadottir
Journal:  Nat Genet       Date:  2014-08-03       Impact factor: 41.307

View more
  7 in total

1.  Prevalence of Germline Mutations Associated With Cancer Risk in Patients With Intraductal Papillary Mucinous Neoplasms.

Authors:  Michael Skaro; Neha Nanda; Christian Gauthier; Matthäus Felsenstein; Zhengdong Jiang; Miaozhen Qiu; Koji Shindo; Jun Yu; Danielle Hutchings; Ammar A Javed; Ross Beckman; Jin He; Christopher L Wolfgang; Elizabeth Thompson; Ralph H Hruban; Alison P Klein; Michael Goggins; Laura D Wood; Nicholas J Roberts
Journal:  Gastroenterology       Date:  2019-02-01       Impact factor: 22.682

2.  Histomorphology of pancreatic cancer in patients with inherited ATM serine/threonine kinase pathogenic variants.

Authors:  Danielle Hutchings; Zhengdong Jiang; Michael Skaro; Matthew J Weiss; Christopher L Wolfgang; Martin A Makary; Jin He; John L Cameron; Lei Zheng; David S Klimstra; Randall E Brand; Aatur D Singhi; Michael Goggins; Alison P Klein; Nicholas J Roberts; Ralph H Hruban
Journal:  Mod Pathol       Date:  2019-07-08       Impact factor: 7.842

3.  Examination of ATM, BRCA1, and BRCA2 promoter methylation in patients with pancreatic cancer.

Authors:  Cancan Zhou; Nancy Porter; Michael Borges; Christian Gauthier; Lindsey Ferguson; Bo Huang; Neha Nanda; Jin He; Daniel Laheru; Ralph H Hruban; Michael Goggins; Alison P Klein; Nicholas J Roberts
Journal:  Pancreatology       Date:  2021-03-28       Impact factor: 3.977

4.  PRSS1 Upregulation Predicts Platinum Resistance in Ovarian Cancer Patients.

Authors:  Linan Xing; Songyu Tian; Wanqi Mi; Yongjian Zhang; Yunyan Zhang; Yuxi Zhang; Fengye Xu; Chunlong Zhang; Ge Lou
Journal:  Front Cell Dev Biol       Date:  2021-01-28

5.  Pancreatic Cancer: A Review of Risk Factors, Diagnosis, and Treatment.

Authors:  ZhiYu Zhao; Wei Liu
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

Review 6.  An Insight into miR-1290: An Oncogenic miRNA with Diagnostic Potential.

Authors:  Małgorzata Guz; Witold Jeleniewicz; Marek Cybulski
Journal:  Int J Mol Sci       Date:  2022-01-22       Impact factor: 5.923

Review 7.  Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.

Authors:  Andrew McGuigan; Paul Kelly; Richard C Turkington; Claire Jones; Helen G Coleman; R Stephen McCain
Journal:  World J Gastroenterol       Date:  2018-11-21       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.